VANCOUVER, Washington, May 27, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140...
VANCOUVER, Washington, April 07, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5...
WESTLAKE VILLAGE, Calif. and BELO HORIZONTE, Brazil, June 03, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) and BIOMM SA (BVMF:BIOM3) today announced that Afrezza® (insulin human...
VALENCIA, Calif. and BELO HORIZONTE, Brazil, May 31, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) and BIOMM SA (BVMF:BIOM3) today announced that they have entered...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.7 | -7.37618545838 | 9.49 | 9.7 | 8.65 | 62967 | 9.34382213 | CS |
4 | -0.28 | -3.08710033076 | 9.07 | 10.2 | 8.48 | 66767 | 9.43012232 | CS |
12 | 0.29 | 3.41176470588 | 8.5 | 11.4 | 8.31 | 75547 | 9.66862359 | CS |
26 | -6.37 | -42.018469657 | 15.16 | 18.89 | 7.79 | 118441 | 12.61611988 | CS |
52 | 2.89 | 48.9830508475 | 5.9 | 21.2 | 5 | 100218 | 12.78857537 | CS |
156 | -4.61 | -34.4029850746 | 13.4 | 21.2 | 3.1 | 44376 | 11.45881762 | CS |
260 | -1.12 | -11.301715439 | 9.91 | 29 | 3.1 | 38458 | 12.93441023 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約